For two years in a row, shares of our healthcare juggernaut UnitedHealth Group have lagged significantly. So, why are we bullish UNH? Find out.

Jeffrey V. Matous, MD, discusses how best practices in transitioning care between academic and community centers can enhance patient outcomes when receiving bispecific antibodies, and the critical ...